456 related articles for article (PubMed ID: 11250717)
1. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis.
Duffy MJ; Maguire TM; Hill A; McDermott E; O'Higgins N
Breast Cancer Res; 2000; 2(4):252-7. PubMed ID: 11250717
[TBL] [Abstract][Full Text] [Related]
2. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review).
Duffy MJ; McCarthy K
Int J Oncol; 1998 Jun; 12(6):1343-8. PubMed ID: 9592197
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL; VanMeter TE; Broaddus WC
J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
[TBL] [Abstract][Full Text] [Related]
5. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
6. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
8. Complex roles of matrix metalloproteinases in tumor progression.
Powell WC; Matrisian LM
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():1-21. PubMed ID: 8814982
[No Abstract] [Full Text] [Related]
9. Matrix metalloproteinases and their inhibitors in tumour growth and invasion.
Kähäri VM; Saarialho-Kere U
Ann Med; 1999 Feb; 31(1):34-45. PubMed ID: 10219712
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells.
Reddy KB; Krueger JS; Kondapaka SB; Diglio CA
Int J Cancer; 1999 Jul; 82(2):268-73. PubMed ID: 10389762
[TBL] [Abstract][Full Text] [Related]
11. Matrix-degrading proteases in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Breast Cancer Res Treat; 1994; 31(2-3):167-73. PubMed ID: 7881096
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases: multifunctional contributors to tumor progression.
McCawley LJ; Matrisian LM
Mol Med Today; 2000 Apr; 6(4):149-56. PubMed ID: 10740253
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in tumour invasion and metastasis.
Curran S; Murray GI
J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
15. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.
Ray JM; Stetler-Stevenson WG
Eur Respir J; 1994 Nov; 7(11):2062-72. PubMed ID: 7533104
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.
Vihinen P; Kähäri VM
Int J Cancer; 2002 May; 99(2):157-66. PubMed ID: 11979428
[TBL] [Abstract][Full Text] [Related]
18. [Metalloproteinases in the extracellular matrix: structure and activity].
Cuvelier A; Kuntz C; Sesboüé R; Muir JF; Martin JP
Rev Mal Respir; 1997 Jan; 14(1):1-10. PubMed ID: 9082500
[TBL] [Abstract][Full Text] [Related]
19. Implications of the new biology for therapy in breast cancer.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 2):76-81. PubMed ID: 8614850
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
